Now showing items 1-3 of 3

    • Duragraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial 

      Ben Ali, Walid; Voisine, Pierre; Olsen, Peter Skov; Jeanmart, Hugues; Noiseux, Nicolas; Goeken, Tracy; Satishchandran, Vilas; Cademartiri, Filippo; Cutter, Garry; Veerasingam, Dave; Brown, Craig; Emmert, Maximilian Y; Perrault, Louis P (BMJ, 2018-04-01)
      Introduction Saphenous vein grafts (SVGs) remain the most often used conduits in coronary artery bypass grafting (CABG). However, they are prone to vein graft disease (VGD) during follow-up, which may compromise clinical ...
    • Fractional flow reserveto guide and to assesscoronary artery bypass grafting 

      Pellicano, Mariano; De Bruyne, Bernard; Toth, Gabor G.; Casselman, Filip; Wijns, William; Barbato, Emanuele (Oxford University Press (OUP), 2016-12-23)
      The aim of this review is to highlight the role of invasive functional evaluation in patients in whom coronary artery bypass graft (CABG) is indicated, and to examine the clinical evidence available in favour of fractional ...
    • Oup accepted manuscript 

      Unknown author (Oxford University Press (OUP), 2017-01-01)
      The primary hypothesis of the ROMA trial is that in patients undergoing primary isolated non-emergent coronary artery bypass grafting, the use of 2 or more arterial grafts compared with a single arterial graft (SAG) is ...